XML 38 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHAREHOLDERS' EQUITY (DEFICIENCY) - Ordinary share capital (Details)
$ in Thousands
1 Months Ended 6 Months Ended 12 Months Ended
Mar. 07, 2022
Jul. 15, 2021
shares
Apr. 30, 2020
shares
Dec. 31, 2019
shares
Jul. 31, 2019
USD ($)
shares
Sep. 30, 2018
USD ($)
shares
Apr. 30, 2016
shares
Jun. 30, 2022
shares
Dec. 31, 2021
Vote
shares
Dec. 31, 2019
shares
Dec. 31, 2020
shares
SHAREHOLDERS' DEFICIENCY                      
Stock split ratio 0.905292                    
Ordinary shares, authorized (in shares)               362,116,800 72,423,360   72,423,360
Ordinary shares, issued (in shares)               68,575,397 40,528,913   40,433,578
Ordinary shares, outstanding (in shares)               68,575,397 40,528,913   40,433,578
Number of Preferred Shares converted into ordinary shares               13,739,186      
Conversion of ordinary shares               14,270,797      
Number of vote entitled to | Vote                 1    
Consideration for issuance of shares | $           $ 29,150          
Number of shares issued   9,053 556,548 5,316,493   7,229,885   12,435,849      
Number of warrants issued           3,614,960 67,897   3,880,777 6,789,694  
HekaBio K.K. [Member]                      
SHAREHOLDERS' DEFICIENCY                      
Number of shares issued         1,302,132            
Number of warrants issued         651,067            
Ordinary shares                      
SHAREHOLDERS' DEFICIENCY                      
Stock split ratio 0.905292                    
Ordinary shares, authorized (in shares)               362,116,800 72,423,360   72,423,360
Ordinary shares, issued (in shares)               68,575,397 40,528,913    
Ordinary shares, outstanding (in shares)               68,575,397 40,528,913    
Ordinary shares | HekaBio K.K. [Member]                      
SHAREHOLDERS' DEFICIENCY                      
Consideration for issuance of shares | $         $ 5,250